Translate
Xilio Therapeutics, Inc.
About
8.35USD+0.10 +1.21%
Closed • Updated at 06:03 GMT+00:00Market Cap$49.96M
Volume22.7K
Beta-0.10
RSI52.79
Gross Margin97.40%
Xilio Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 12 2026
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
May 7 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 17 2026
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
Apr 16 2026
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
Mar 23 2026
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
Recent Videos
Xilio Therapeutics Appoints Cheryl Blanchard to Board
Apr 16, 2026
Xilio Therapeutics Inc. 2025 annual report
Mar 26, 2026
02_12_26 Biotech Stock News. Daily Recap. #English #Shorts $XBI #trading #biotechnews #dailynews
Feb 12, 2026
Xilio Therapeutics: My Take on Their Survival Strategy
Jan 21, 2026
Community Chat
Ask AI
Try asking